doi: 10.3389/fpls.2025.1548003 14 SchusterJKnillTReicheltMGershenzonJBinderS
GI effects from GLP-1 receptor agonists are mechanistic, dose-dependent, and tend to ease as the body adjusts to maintenance doses.[1],[2] What probiotics may reasonably offer: Support for gut microbiome balance during altered transit and reduced food intake Strain-level evidence relevant to gut-microbiome-mediated metabolic biology Complementary support that runs alongside the medication, not as a treatment for its side effects What probiotics do not do: Reverse delayed gastric emptying Substitute for clinician-guided dose escalation Treat severe or persistent symptoms that warrant medical attention WONDERBIOTICS Probiotics for Weight Management is one non-treatment-claim option in the probiotic category, with honest framing about scope
Rong et al
While studies have looked at the effects of GLP-1 receptor agonists (RAs) on the pharmacokinetics of these medications the data is still limited
competitive sports participants (people using AAS to enhance performance, including both professional and amateur athletes), occupational users (people using AAS to enhance physical ability or appearance related to their job, e.g
Drizzle the melted chocolate over the tops of the banana mixture in the popsicle molds
